BioAffinity Technologies Inc.
Price
Key statistics
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
BioAffinity Technologies Inc. is a biotechnology company focused on noninvasive diagnostics for early-stage lung cancer and other diseases of the lung. Its core offering is CyPath Lung, a laboratory-developed test that uses flow cytometry and automated analysis of sputum samples to identify cell populations associated with cancer. The company operates through two main business segments, Diagnostic Research and Development and Laboratory Services, combining test development with clinical laboratory activity. BioAffinity Technologies also works on targeted cancer therapeutics and other proprietary diagnostic platforms designed to support earlier disease detection and more precise analysis of biological samples. Based in San Antonio, Texas, BioAffinity Technologies serves the health technology and medical diagnostics market with products aimed at improving lung disease detection and diagnostic workflows.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- CEO
- Ms. Maria Zannes J.D.
- Employees
- 57
- Headquarters
- San Antonio, TX, United States
- Website
- bioaffinitytech.com